Home
overview

SMi proudly presents its inaugural Drug Discovery conference in London, 2017!

In recent years, the Pharmaceutical/Biotech industry has undergone radical changes which have increased our understanding of drug discovery and development, however there are still many hurdles that the industry face.

The gap between a laboratory discovery and an approved drug on the market is a decade-long process of laboratory testing, evaluation in animal models and human clinical trials that can cost hundreds of millions of dollars. SMi's inaugural Drug Discovery conference 27th-28th March 2017 aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges.

The conference will bring together industry leaders who will highlight future opportunities for novel therapeutic discovery.

The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.*

Now is the time to invest and join us next March for SMi's inaugural Drug Discovery conference!

 *http://www.bccresearch.com/market-research/biotechnology/dna-sequencing-technology-bio045e.html

 

Ariad Pharmaceuticals; AstraZeneca; atugen AG; BioFocus Plc; Biotech; Biowisdom; Bristol-Myers Squibb Company; Centre For The Economics Of Mental Health Institute Of Psychiatry; Devgen; ESBA Tech AG; Exelixis; G E Healthcare; Gendaq; GeneData; GeneTrove; GenKyoTex; GlaxoSmithKline; Hybridgenics; Incyte Genomics Limited; Kinetek Pharmaceuticals; Lion Bioscience; LION Bioscience AG; Lovells; Millennium Pharmaceuticals; None; Novartis; Oxford BioMedica (U K) Limited; Oxrford Biomedica; Personal Chemistry Ltd; Pfizer; Pharma Matters; Phase 1 Molecular Toxicology; Quintiles (UK) Ltd; Sangamo Biosciences; Tabriz Consulting Ltd ;

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

9:10 Transforming and Translating Drug Discovery – Use of the CRISPR/Cas9 Technology in Target Discovery, Hit Finding and Translational Studies

Lorenz Mayr

Lorenz Mayr, Vice President and Global Head, Reagents & Assay Development, AstraZeneca

• Overview of PGE and introduction to CRISPR/Cas9
technology
• Applications in target fi nding, hit & lead discovery,
effi cacy & safety models
• AstraZeneca’s unique approach towards innovation
& collaboration
• Case studies from AstraZeneca’s drug discovery
programmes
• Future outlook of PGE for drug discovery & therapeutic
applications

9:55 Quality by design in support of early discovery

Stephen  Pickett

Stephen Pickett, Senior Scientific Investigator, GSK Fellow, GlaxoSmithKline

 

 

 

-Designing a compound collection to support different screening paradigms

-Maximizing information from high throughput and phenotypic screening

-Predictive modeling to support lead generation and optimization
 

10:35 Morning Coffee

10:55 Orion: CADD reimagined as a cloud enterprise

Anthony Nicholls

Anthony Nicholls, President, CEO, OpenEye Scientific Software

11:35 Using FBDD to rapidly generate tool compounds across different protein classes.

Steve Swann

Steve Swann, Senior Research Chemist - Fragment-Based Drug Design, Abbott

• The convergence of fragments, compound quality and
clinical success
• Using fragments and SBDD to accelerate lead
optimisation
• Answering key pharmacology questions with fragment
derived lead assets

12:15 Networking Lunch

13:15 Fragments for drug discovery and chemical biology

• Recent experience with conventional (kinases) and more
challenging (Bcl-2 and Mcl-1) targets
• Current topics in fragment methods - 3D fragments,
off-rate screening
• Fragments for chemical biology (antimicrobial target ID
and activating industrial enzymes)

Roderick  Hubbard

Roderick Hubbard , Senior Fellow, Vernalis Research Ltd

13:55 Structure based drug discovery on membrane protein targets: New developments and advancements

Michael Hennig

Michael Hennig, CEO, leadXpro AG

• Structure based drug discovery for soluble proteins
is routinely used in pharmaceutical industry, but
transmembrane proteins are still challenging
• Progress in membrane protein expression, purifi cation
and solubilization as well as use of serial crystallography
at synchrotron and Free Electron Laser (FEL)
• Recent developments on single particle cryo-Electron
Microscopy for high resolution structure determination
• Outline of new opportunities for hit and lead discovery
using information derived from biophysical methods and
structures of membrane protein drug targets

14:35 Afternoon Tea

14:55 Large scale analysis of a pharmaceutical company database to inform future drug discovery

Lewis Vidler

Lewis Vidler, Research Scientist, Eli Lilly & Co

• Analysis of the Lilly database will be presented with a
particular focus on compounds showing promiscuous or
assay interfering behaviour
• Looking at an approach involving compound
fragmentation and analysis of molecules containing the
fragments
• Identifying fragments enriching for compound
promiscuity, instability and cytotoxicity

15:35 Approaches to identify small molecule binders and more

Marta Westwood

Marta Westwood, Senior Scientist, UCB Pharma Limited

·         Understanding the target protein

·         Molecular dynamics and use of antibodies as tools to sample protein conformations

·         Technologies to detect conformational change in the target protein upon small molecule binding

 

16:15 Phenotypic screening in drug discovery

Ulrich Schopfer

Ulrich Schopfer, Executive Director, Integrated Lead Discovery Head, Novartis

• Overcoming the considerable challenges with
phenotypic screening
• Optimising success factors
• How Novartis’s efforts in phenotypic screening have
influenced our approach to drug discovery

16:50 Chairman’s Closing Remarks and Close of Day One

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Guido Hanauer

Guido Hanauer, Scientific Director Translational Medicine, Takeda

9:10 Is translational medicine capable to increase success rate in the pharmaceutical industry?

Guido Hanauer

Guido Hanauer, Scientific Director Translational Medicine, Takeda

• Tasks of translational medicine
• Tools used in translational medicine
• Critical evaluation of these tools
• Reinventing translational medicine

9:50 Advancing structural information of ligand-receptor complexes

Matthias Frech

Matthias Frech, Director Molecular Interactions and Biophysics, Merck KGaA

• Insights into receptor activation from agonist
and antagonist structures
• Probabilistic outcomes of molecular recognition,
limitations to models and matching unique events
• Controlling lypophilicity and MW to optimise molecular
recognition
• High-quality 3D models of GPCRs and to perform
molecular dynamics simulations

10:30 Morning Coffee

10:50 The challenges of working with difficult targets

Helen Boyd

Helen Boyd , Associate Director, AstraZeneca

- Ubiquitin E3 ligases and DUB’s: Important enzymes in a number of disease states
- IDOL a unique E3 ligase and its role in regulating LDL cholesterol levels
- Challenges involving hit identification and lead optimization

11:30 Determination of high-resolution X-ray structures of G protein-coupled receptors (GPCRs) to discover new drug lead compounds

Nigel  Swain

Nigel Swain, Senior Medicinal Chemist , Heptares Therapeutics

• Combination of technologies that has the potential
to accelerate the delivery of structural information
for drug discovery efforts
• Case study: StaR® protein and structure-based drug
design platform
• What the future holds for GPCR structure based drug
discovery

12:10 Networking Lunch

13:10 Current developments in high-content imaging and machine learning applications in drug discovery

Yolanda Chong

Yolanda Chong, Principal Scientist, Janssen Pharmaceutica NV

• Exploring new technologies that allow for acquisition
of high-dimensional biological data
• Phenomics: next generation phenotypic screening
methods for the drug discovery pipeline
• Applying phenomic analysis to uncover compound
cellular mechanism of action

13:50 Application of enabling chemistry technology to the acceleration of the drug discovery process

Stevan Djuric

Stevan Djuric, Senior Director Discovery Chemistry and Technology, AbbVie

·         Flow chemistry platforms including

-          Compound library synthesis using segmented flow,

-          photochemistry

-          electrochemistry

-          high temperature chemistry to access novel heterocycles

·         MS based analytical technologies applied to

-          Drug Distribution

-          Product Protection

 

14:30 Afternoon Tea

14:50 Expanding the chemical space using NPs: Internal approaches & collaborations

Werngard  Czechtizky

Werngard Czechtizky, Section Head, Medicinal Chemistry, Sanofi-Aventis

• Overview on Sanofi natural products
• NP based collaborations
• Toxins – from isolation to synthesis and structure
elucidation
• TAFIa inhibition – converting a NP to a potent SM lead
compound

15:30 Multi-Organ-Chip developments: Towards a paradigm shift in drug development?

Reyk Horland

Reyk Horland, Head of Business Development, Tissuse G Mb H

• ‘Human-on-a-chip’ technology allows us to closely
study organoid interaction
• Allows more representative drug toxicity and effi cacy
screening. Could this be the end of preclinical trials as
we know them?
• Closing the gap between in vivo and in vitro; the
importance of highly physiologically relevant cultures
and microenvironments

16:10 Chairman’s Closing Remarks and Close of Day Two

Guido Hanauer

Guido Hanauer, Scientific Director Translational Medicine, Takeda

+

FEATURED SPEAKERS

Guido Hanauer

Guido Hanauer

Scientific Director Translational Medicine, Takeda
Helen Boyd

Helen Boyd

Associate Director, AstraZeneca
Matthias Frech

Matthias Frech

Director Molecular Interactions and Biophysics, Merck KGaA
Stevan Djuric

Stevan Djuric

Senior Director Discovery Chemistry and Technology, AbbVie

Anthony Nicholls

President, CEO, OpenEye Scientific Software
Anthony Nicholls

Guido Hanauer

Scientific Director Translational Medicine, Takeda
Guido Hanauer

Helen Boyd

Associate Director, AstraZeneca
Helen Boyd

Lewis Vidler

Research Scientist, Eli Lilly & Co
Lewis Vidler

Lorenz Mayr

Vice President and Global Head, Reagents & Assay Development, AstraZeneca
Lorenz Mayr

Marta Westwood

Senior Scientist, UCB Pharma Limited
Marta Westwood

Matthias Frech

Director Molecular Interactions and Biophysics, Merck KGaA
Matthias Frech

Michael Hennig

CEO, leadXpro AG
Michael Hennig

Nigel Swain

Senior Medicinal Chemist , Heptares Therapeutics
Nigel  Swain

Reyk Horland

Head of Business Development, Tissuse G Mb H
Reyk Horland

Roderick Hubbard

Senior Fellow, Vernalis Research Ltd
Roderick  Hubbard

Stephen Pickett

Senior Scientific Investigator, GSK Fellow, GlaxoSmithKline
Stephen  Pickett

Stevan Djuric

Senior Director Discovery Chemistry and Technology, AbbVie
Stevan Djuric

Steve Swann

Senior Research Chemist - Fragment-Based Drug Design, Abbott
Steve Swann

Ulrich Schopfer

Executive Director, Integrated Lead Discovery Head, Novartis
Ulrich Schopfer

Werngard Czechtizky

Section Head, Medicinal Chemistry, Sanofi-Aventis
Werngard  Czechtizky

Yolanda Chong

Principal Scientist, Janssen Pharmaceutica NV
Yolanda Chong

Sponsors and Exhibitors

Official Media Partner

Official Publication

Supporters

Workshops

New Approaches in lead generation: Towards drugs for every targets?
Workshop

New Approaches in lead generation: Towards drugs for every targets?

Holiday Inn Kensington Forum
29th March 2017
London, United Kingdom

VENUE

Holiday Inn Kensington Forum

97 Cromwell Road , London, United Kingdom

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

HOTEL BOOKING FORM

Interview with Eli Lilly

Download

Sponsors and Exhibitors


Cisbio Bioassays

Sponsors and Exhibitors
http://www.cisbio.com/

Cisbio Bioassays develops and markets products and technologies used for in vitro diagnostics and drug discovery. With its proprietary technology, HTRF®, the company is a leader in homogeneous fluorescence detection methods, and offers first class assays and services for drug discovery researchers. In addition, Cisbio Bioassays provides a broad range of immunoassays for in vitro diagnostics, mainly tailored for cancerous pathologies, as well as metabolic and auto-immune diseases. Based in Codolet, France, Cisbio Bioassays owns facilities in Bedford, MA, U.S.A., Shanghai, China, and Tokyo, Japan, and also markets its global offer through a network of distributors.


OpenEye Scientific Software

Sponsors and Exhibitors
http://www.eyesopen.com/

OpenEye Scientific Software develops large-scale applications and toolkits for drug design and molecular modeling. The software is designed for scientific rigor, speed, scalability and platform independence. Its primary aim is virtual screening and lead-hopping. Areas of expertise include cheminformatics, conformer generation, docking, shape comparison, electrostatics, crystallography and visualization.

Media Partners


Chimica Oggi – Chemistry Today

Official Media Partner
http://www.teknoscienze.com

Chimica Oggi – Chemistry Today, the international journal of Fine Chemicals, Applied Chemistry and Biotechnology, is a peer reviewed, bimonthly journal, specialized in fine chemistry, pharmaceuticals, analytical technologies, chemical engineering and biotechnology of the TKS – TeknoScienze Publisher. Founded in 1983 Chimica Oggi – Chemistry Today soon became a leading journal in linking industry and academia and gained an immediate appreciation.

Media Partners


International Journal of Biomedical Engineering and Technology

Official Publication
http://www.inderscience.com/ijbet

IJBET addresses cutting-edge research in the multi-disciplinary area of biomedical engineering and technology. Medical science incorporates scientific/technological advances combining to produce more accurate diagnoses, effective treatments with fewer side effects, and improved ability to prevent disease and provide superior-quality healthcare. A key field here is biomedical engineering/technology, offering a synthesis of physical, chemical, mathematical and computational sciences combined with engineering principles to enhance R&D in biology, medicine, behaviour, and health. IJBET includes the Asia-Pacific Chapter in Biomedical Wireless Technology (APC-BWT).


Int. J. of Biotechnology

Official Publication
http://www.inderscience.com/ijbt

IJBT provides an international forum and refereed authoritative source of information in the field of Biotechnology and Biotechnics, with emphasis on management and economics, as well as the political and social issues. It aims to disseminate knowledge, provide a learned reference in the field, and establish channels of communication between academic and research experts, policy makers and executives in industry, commerce and investment institutions.


International Journal of Bioinformatics Research and Applications

Official Publication
http://www.inderscience.com/ijbra

Bioinformatics is an interdisciplinary research field that combines biology, computer science, mathematics and statistics into a broad-based field that will have profound impacts on all fields of biology. The emphasis of IJBRA is on basic bioinformatics research methods, tool development, performance evaluation and their applications in biology. IJBRA addresses the most innovative developments, research issues and solutions in bioinformatics and computational biology and their applications.


International Journal of Medical Engineering and Informatics

Official Publication
http://www.inderscience.com/ijmei

IJMEI promotes an understanding of the structural/functional aspects of disease mechanisms and the application of technology towards the treatment/management of such diseases. It seeks to promote interdisciplinary collaboration between those interested in the theoretical and clinical aspects of medicine and to foster the application of computers and mathematics to problems arising from medical sciences. IJMEI includes authoritative review papers, the reporting of original research, and evaluation reports of new/existing techniques and devices. Each issue also contains a comprehensive information service.


International Journal of Computational Biology and Drug Design

Official Publication
http://www.inderscience.com/ijcbdd

IJCBDD, an International Society of Intelligent Biological Medicine official journal, bridges the gap between two very important, complementary disciplines, computational biology and drug design. Through advances in high-throughput genome sequencing and digital imaging technologies, biocomputing, drug design and medical research have unfolded new, predictive sciences such as genomics, proteomics, lipidomics, metabolomics, cytomics and pharmaconomics. These promote new computational, statistical and biomedical approaches to drug design/development, besides unleashing the potential of significantly more accurate, effective personalised diagnosis, therapeutics and patient care.

Media Partners


Mednous

Supporters
http://www.MedNous.com

MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


Biosave

Supporters
http://www.Biosave.com

Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


Medical News Today

Supporters
http://www.medicalnewstoday.com

Medical News Today is the largest independent medical and health news site on the web - with over 10,000,000 monthly unique users it is ranked number one for medical news on all major search engines. Medical News Today is used by pharmaceutical, biotech and health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted campaigns to HCPs, patients and caregivers. To find out how Medical News Today can help you to reach the right audience contact peter@medicalnewstoday.com or visit www.medicalnewstoday.com.


Pharmacircle

Supporters
http://www.pharmacircle.com

PharmaCircle is an innovative knowledge management company serving the current and future global leaders in the Pharmaceutical and Biotechnology related industries. PharmaCircle is a one stop information and analysis source for pipeline, products, clinical trials, drug delivery technologies, deals and acquisitions, company financials, venture capital investments, product sales, pharmaceutical services, news, patents and more….


Absave

Supporters
http://www.absave.com

Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


Labiotech.eu

Supporters
http://labiotech.eu

Labiotech.eu is the leading digital media covering the European Biotech industry. It is used by over 35,000 people monthly to keep a watch on the business and innovations of biotechnologies.


BioChem Adda

Supporters
https://www.biochemadda.com/

BioChem Adda is a Not-just-for-Profit organization which aims to bring out the most reliable and transparent information about everything related to jobs, careers, education, news, articles, and events from the field of BioSciences and Chemistry!


Drug Discovery Today

Supporters
http://www.drugdiscoverytoday.com/

Drug Discovery Today is one of the most cited review journals in the field of drug discovery, with an impact factor of 6.422.
Drug Discovery Today will benefit your research by helping to keep you up-to-date with all of the fast-moving and emerging topics in drug discovery. Each issue is packed full of the latest research news, peer-reviewed articles and comment and opinion from leading research scientists.


SelectScience

Supporters
http://www.selectscience.net/register?utm_source=Media-Partner&utm_medium=Website&utm_campaign=SMI

SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover the latest drug discovery and development technologies, products and techniques with product reviews, videos, application notes and news articles. Become a member for free today.


Inderscience Publishers

Supporters
http://www.inderscience.com

Inderscience is a dynamic, leading, independent journal publisher. The company disseminates the latest research across the broad fields of science, engineering and technology; management, public and business administration; environment, ecological economics and sustainable development; computing, ICT and internet/web services, and related areas. Inderscience offers over 35 years' experience in publishing and has succeeded in building a substantial collection approaching 400 high-quality peer-reviewed international research journals in both online and print formats. We offer a variety of ways to keep up-to-date with the latest published leading-edge research while our online collection represents a fully-searchable digital archive of around 60,000 articles.


Pharmaceutical Technology

Supporters
http://www.pharmaceutical-technology.com

Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


International Pharmaceutical Industry

Supporters
http://www.ipimediaworld.com

IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


Pharmavision

Supporters
http://www.pharmavision.co.uk

PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


Labsave

Supporters
http://www.labsave.com

Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


Farmavita

Supporters
http://www.farmavita.net/

Farmavita Net is professional community and network of pharmaceutical licensing and business development executives, innovators and researchers
Farmavita.Net is the pharmaceutical licensing, technology transfer and regulatory affairs network. We are managing the marketplace of offers and demand for pharmaceutical Dossiers, know-how and technologies. Members of Farmavita.Net network usually find a number of attractive solutions for business development, alliances, joint ventures, co-development and co-marketing of pharmaceutical products. Farmavita.Net is not just a pure Internet portal. We manage a number of regional associates. We are connecting the dynamic network of few hundreds members / pharmaceutical companies interested in license-in and license-out opportunities.


Swiss Biotech Association

Supporters
http://www.swissbiotech.org/

The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


Technology Networks

Supporters
http://www.technologynetworks.com

Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


Pharmalicensing

Supporters
http://www.pharmalicensing.com

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing, and its sister service Medical Device Licensing (www.medicaldevicelicensingcom) are actively utilized by over 200,000 industry professionals each month. Pharmalicensing is a division of IP Technology Exchange, Inc.


Drug Development Technology

Supporters
http://www.drugdevelopment-technology.com

Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


evvnt Ltd

Supporters
http://www.evvnt.com

evvnt enables people all over the world to fill their events utilising the most effective event listing sites on the web. Every minute, with little more than a click, more events and conferences appear in listings, in search engines and on mobile - discoverable by both category and location. With next to no effort customers of evvnt get better attendance, while consumers find events they previously had no idea existed. To date customers in 70 countries worldwide have submitted over 500,000 thousand event listings, created over 300,000 live links, and generated 1 million clicks to ticketing and registration pages. Learn more at www.evvnt.com

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Holiday Inn Kensington Forum

97 Cromwell Road
London SW7 4DN
United Kingdom

Holiday Inn Kensington Forum

Holiday Inn Kensington Forum is perfectly situated in one of London’s most luxurious and beautiful areas within South Kensington. 

The hotel is just 2 minutes walk from Gloucester Road tube station for convenient travel to Hyde Park, London Eye, Tower Bridge plus more of London’s top attractions. There are also easy and direct links to some major transport hubs including Victoria, Kings Cross St Pancras, Paddington and Heathrow. 

This distinctive hotel in south London has so much to offer to make all guests really feel at home. The latest Holiday Inn relaunch is not just about the new look and feel for the hotel but to offer guests more benefits during their stay including a pillow menu for extra comfort during their sleep and a curved shower rail for more spacious feel. 

In addition to our 906 rooms, all business guests can take advantage of our meeting and conference facilities including High Speed Internet Access and unlimited Starbucks coffee at The Academy. Our hotel’s professional event planners are on board to help take the hard work and stress away from planning your next event. 

So whether you in London on business or pleasure, make the Holiday Inn London Kensington Forum your first choice of hotel and book your accommodation for our lowest internet rate guarantee. 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.